Nebenwirkungen · Advate
ADVATE 250 IU/5 ml powder and solvent for solution for injection ADVATE 500 IU/5 ml powder and solvent for solution for injection ADVATE 1 000 IU/5 ml powder and solvent for solution for injection ADVATE 1 500 IU/5 ml powder and solvent for solution for injection ADVATE 2 000 IU/5 ml powder and solvent for solution for injection ADVATE 3 000 IU/5 ml powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 6
HOS-112439 · Präparat HOS-093675
Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93 adverse drug reactions (ADRs). The ADRs that occurred in the highest frequency were development of neutralising antibodies to factor VIII (inhibitors), headache and fever.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-23T12:20:00Z · SHA-256 1676714d819bb0bd275e9f7e4eb6349a64035cde34acd2a9aa639c8e0ad4123b · Passage 027fd64f714d01399084c334bd38395573b83bc8fbec98e49163a4ca15b5e10b · Zeichen 31–312 im Abschnitt